ACXP·00510M203·US·equity·Healthcare - Biotechnology-13D/G
ACXP (ACURX PHARMACEUTICALS INC) is held by 10 institutional investors as of Q1 2026. Largest holders: JANE STREET GROUP, LLC ($202,722), GEODE CAPITAL MANAGEMENT, LLC ($92,080), MORGAN STANLEY ($24,115). Net institutional sentiment: Mixed.
See how ACXP's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer